Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.

Can genetic editing help improve the overall health of people living with type 1 diabetes? The results of a recent study ...

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

Researchers have been searching for a diabetes cure or a long-term solution for managing type 1 diabetes for decades now. They not only have to find a way to restore insulin production but also need ...

A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered ...

The procedure, carried out by researchers at Uppsala University in Sweden, allowed the patient to begin producing small amounts of his own insulin for the first time in years ...

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

Technology Networks interviewed the Salk Institute's Professor Alan Saghatelian about his latest research using CRISPR-based ...

Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...